Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
Use this JANX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the JANX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the JANX SEC filings page. Lician reads the product cache first so this HTML stays unique to Janux Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full JANX income, balance, and cash tables.